FDA
approval
· 2021-10-13
FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
Summary
The FDA approved a supplemental application for Allegra Hives 24HR, a fexofenadine hydrochloride product from Chattem, expanding its labeling for hives.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ALLEGRA HIVES 24HR (FEXOFENADINE HYDROCHLORIDE)